, Wen, Z
MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer
Speed of weight loss This is the single biggest predictor
QD community oral or SC MOTS-c Daily SC, often 5 days on / 2 off AOD-9604 Daily SC Attribute Max studied dose SLU-PP-332 50 mg/kg BID (mouse, 28 days) MOTS-c 5-15 mg/kg (mouse) AOD-9604 1-5 mg/day in human Phase 2 Attribute Peak efficacy signal SLU-PP-332 ~25-30% fat-mass reduction in DIO mice over 28 days MOTS-c Improved insulin sensitivity in aged mice AOD-9604 Modest fat-loss signal in human Phase 2
That said, dose adjustment may help: Slowing titration Staying at a lower dose longer Splitting the weekly dose (only under provider supervision) Peptides That May Help Certain peptides may complement GLP-1 therapy and relieve associated constipation: BPC-157 : Promotes gut healing, modulates inflammation, and may enhance motility KPV : Anti-inflammatory tripeptide that supports intestinal barrier and microbiota GHK-Cu : May regulate repair pathways and microbiome balance A Sample Integrative Protocol Here is a practical, foundational plan for anyone on a GLP-1 medication experiencing constipation: Morning: Warm water with lemon 1 scoop ProbioHealth 350 in water 2 caps ActiveMulti , 2 caps Multi-Mineral Optional: 1-2 caps EZ-Go if not having daily bowel movements Midday: 1-2 tsp ground flaxseed or chia in smoothie or meal Light walk after lunch Evening: Mag Citrate or vitamin C powder to bowel tolerance Wind-down yoga, breathing, or vagal stimulation practice Weekly: Assess progress Adjust supplements as needed Schedule a Micronutrient Lab review Final Thoughts: Constipation Is Common, But It Is Fixable GLP-1 medications are a major advancement in metabolic medicine
Hydrocortisone-ascorbic acid-thiamine use associated with lower mortality in pediatric septic shock
